July 17th 2025
Frank Kerkhoff, MD, shares his experiences with the Johnson & Johnson Tecnis Odyssey lens
Best way to measure accommodation
August 18th 2008Defocus curve measurement of subjective amplitude of accommodation (AoA) is not affected by non-randomized letter sequences in presbyopic subjects, according to results of a study published in the August 2008 issue of the Journal of Cataract & Refractive Surgery.
STAAR lenses granted NTIOL status
August 4th 2008The Afinity Collamer aspheric single piece Intraocular Lens (IOL) Model CC4204A and the Elastimide Silicone aspheric IOL Model AQ2015A, both manufactured and marketed by STAAR Surgical, have been designated New Technology IOLs (NTIOLs) by the US Centers for Medicare and Medicaid.
Survey assesses life quality for adults with strabismus
July 21st 2008A 20-item questionnaire is expected to be useful for evaluating the health-related quality of life of adults with strabismus and practical application in a clinical setting. The patient-derived questionnaire assesses both psychosocial and functional aspects of strabismus.
Study evaluates safety of intracameral moxifloxacin
June 30th 2008The safety of intracameral moxifloxacin (Vigamox, Alcon Laboratories) for post cataract surgery endophthalmitis prophylaxis was investigated in a prospective, randomized, controlled study. Statistical analyses of multiple postoperative outcome measures demonstrated no significant differences between patients who received intracameral moxifloxacin and controls treated with intracameral balanced salt solution.
NSAID activity at trough drug levels
June 23rd 2008Animals undergoing lens removal surgery were treated with non-steroidal anti-inflammatory drugs pre- and postoperatively. On the first day after surgery, aqueous humor samples were taken at times corresponding to trough drug levels. The mean aqueous prostaglandin E2 concentration was significantly lower in animals being treated with ketorolac 0.4% (Acular LS, Allergan) compared with those receiving bromfenac 0.09% (Xibrom, ISTA Pharmaceuticals).